Skip to main content

and
  1. Article

    Open Access

    Regulatory (FoxP3+) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer

    Antitumor immune responses induced by immune checkpoint inhibitors anti-PD-1 or anti-PD-L1 have been used as therapeutic strategies in advanced non-small cell lung cancer (NSCLC) patients over the last decade....

    Jiae Koh, Joon Young Hur, Kyoung Young Lee, Mi Soon Kim in Scientific Reports (2020)